Alle verbonden artikelen

Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.

Auteurs : Goss PE, Smith IE, + collaborators (among others :, Piccart-Gebhart M, Finkelstein DM
Jaar : 2013
Journal : Lancet Oncol
Volume : 14(1)
Pagina's : 88-96

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement.

Auteurs : Azim HA, Michiels S, Zagouri F, Delaloge S, Filipits M, Namer M, Neven P, Symmans WF, Thompson A, André F, Loi S, Swanton C
Jaar : 2013
Journal : Ann Oncol
Volume : 24(3)
Pagina's : 647-54

Desire for formal psychological support among caregivers of patients with cancer: prevalence and implications for screening their needs. (epub online 2012)

Auteurs : Merckaert I, Libert Y, Lieutenant F, Moucheux A, Farvacques C, Slachmuylder JL, Razavi D
Jaar : 2013
Journal : Psychooncology
Volume : 22(6)
Pagina's : 1389-95

Magnitude of Trastuzumab Benefit in Patients With HER2-Positive, Invasive Lobular Breast Carcinoma: Results From the HERA Trial.

Auteurs : Metzger-Filho O, Procter M, de Azambuja E, Leyland-Jones B, Gelber Rd, Dowsett M, Loi S, Saini KS, Cameron D, Untch M, Smith I, Gianni L, Baselga J, Jackisch C, Bell R, Sotiriou C, Viale G, Piccart-Gebhart M
Jaar : 2013
Journal : J. Clin. Oncol.
Volume : 31(16)
Pagina's : 1954-60

Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience.

Auteurs : Metzger-Filho O, de Azambuja E, Bradbury I, Saini KS, Bines J, Simon SD, Dooren VV, Aktan G, Pritchard KI, Wolff AC, Smith I, Jackisch C, Lang I, Untch M, Boyle F, Xu B, Baselga J, Perez EA, Piccart-Gebhart M
Jaar : 2013
Journal : Oncologist
Volume : 18(2)
Pagina's : 134-40

A Randomized Study of Interferon a-2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma.

Auteurs : Bosly A, Grigg A, Holte H, Gisselbrecht C, Radford J, Rossi A, Lopez-Guillermo A, Trneny M, Sebban C, Hagberg H, Leal da Costa F, Colombat P, Bron D, Coiffier B
Jaar : 2013
Journal : Oncologist
Volume : 18(11)
Pagina's : 1189

Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial.

Auteurs : Partridge AH, Gelber S, Piccart-Gebhart M, Focant F, Scullion M, Holmes E, Winer EP, Gelber Rd
Jaar : 2013
Journal : J. Clin. Oncol.
Volume : 31(21)
Pagina's : 2692-8

Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.

Auteurs : Kerklaan BM, Diéras V, Le Tourneau C, Mergui-Roelvink M, Huitema AD, Rosing H, Beijnen JH, Marreaud S, Govaerts AS, Piccart-Gebhart M, Schellens JH, Awada A
Jaar : 2013
Journal : Cancer Chemother Pharmacol
Volume : 71(1)
Pagina's : 53-62

Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding?

Auteurs : Pistilli B, Bellettini G, Giovannetti E, Codacci-Pisanelli G, Azim HA, Benedetti G, Sarno MA, Peccatori FA
Jaar : 2013
Journal : Cancer Treat Rev
Volume : 39(3)
Pagina's : 207-11

Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells.

Auteurs : André T, Meuleman N, Stamatopoulos B, De Bruyn C, Pieters K, Bron D, Lagneaux L
Jaar : 2013
Journal : PLoS One
Volume : 8(3)
Pagina's : e59756

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98.

Auteurs : Loi S, Sirtaine N, Piette F, Salgado R, Viale G, Van Eenoo F, Rouas G, Francis P, Crown JP, Hitre E, de Azambuja E, Quinaux E, Di Leo A, Michiels S, Piccart-Gebhart M, Sotiriou C
Jaar : 2013
Journal : J. Clin. Oncol.
Volume : 31(7)
Pagina's : 860-7

Rational approach of leucocytosis in adults].

Auteurs : Bron D
Jaar : 2013
Journal : Rev Med Brux
Volume : 34(4)
Pagina's : 339-42

Stratified medicine: a call for action.

Auteurs : Jacob I, Awada A, Payne K, Annemans L
Jaar : 2013
Journal : Expert Rev Pharmacoecon Outcomes Res
Volume : 13(3)
Pagina's : 277-9

Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.

Auteurs : Azim HA, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, De Mattos-Arruda L, Pistilli B, Pinto A, Jensen MB, Cordoba O, de Azambuja E, Goldhirsch A, Piccart-Gebhart M, Peccatori FA
Jaar : 2013
Journal : J. Clin. Oncol.
Volume : 31(1)
Pagina's : 73-9

An ELCWP phase III trial comparing ifosfamide and cisplatin regimens in advanced NSCLC.

Auteurs : Berghmans T, Lafitte JJ, Scherpereel A, Paesmans M, Lecomte J, Marco VG, Meert AP, Leclercq N, Sculier JP
Jaar : 2013
Journal : Anticancer Res
Volume : 33(12)
Pagina's : 5477-82

Variations in catheter-related bloodstream infections rates based on local practices.

Auteurs : Cherifi S, Mascart G, Dediste A, Hallin M, Gerard M, Lambert ML, Byl B
Jaar : 2013
Journal : Antimicrob Resist Infect Control
Volume : 2(1)
Pagina's : 10

Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Jaar : 2013
Journal : Int. Immunopharmacol.
Volume : 15(4)
Pagina's : 693-702

CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01).

Auteurs : Pestalozzi BC, Holmes E, de Azambuja E, Metzger-Filho O, Hogge L, Scullion M, Láng I, Wardley A, Lichinitser M, Sanchez RI, Müller V, Dodwell D, Gelber Rd, Piccart-Gebhart M, Cameron D
Jaar : 2013
Journal : Lancet Oncol
Volume : 14(3)
Pagina's : 244-8

Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study.

Auteurs : Awada A, Garcia AA, Chan S, Jerusalem GH, Coleman RE, Huizing MT, Mehdi A, + collaborators (among others :, Hannah AL, Perez EA
Jaar : 2013
Journal : Lancet Oncol
Volume : 14(12)
Pagina's : 1216-25

Breast Cancer. Side Effects of Medical Cancer Therapy: Prevention and Treatment. Ed. Mario A. Dicato. Chapter 2: P29-117; Springer 2013, XIII.

Auteurs : Aftimos P, Gombos A, Pugliano L, Awada A, Piccart-Gebhart M
Jaar : 2013
Journal : Book
Volume : chapter2
Pagina's : P29-117